Legato Capital Management’s Globus Medical GMED Stock Holding History

Legato Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$845K	Buy	10,689 +3,680	+53%	+$313K	0.07%	397
2026 Q1	$604K	Sell	7,009 -16,219	-70%	-$1.46M	0.06%	492
2025 Q4	$2.03M	Buy	23,228 +595	+3%	+$45.2K	0.17%	188
2025 Q3	$1.3M	Hold	22,633	–	–	0.14%	227
2025 Q2	$1.34M	Hold	22,633	–	–	0.16%	203
2025 Q1	$1.66M	Sell	22,633 -289	-1%	-$23.9K	0.22%	135
2024 Q4	$1.9M	Hold	22,922	–	–	0.25%	116
2024 Q3	$1.64M	Hold	22,922	–	–	0.2%	159
2024 Q2	$1.57M	Hold	22,922	–	–	0.21%	165
2024 Q1	$1.23M	Buy	22,922 +4,642	+25%	+$250K	0.15%	232
2023 Q4	$974K	Hold	18,280	–	–	0.13%	274
2023 Q3	$908K	Buy	18,280 +2,085	+13%	+$117K	0.13%	268
2023 Q2	$964K	Hold	16,195	–	–	0.13%	269
2023 Q1	$917K	Hold	16,195	–	–	0.17%	214
2022 Q4	$1.2M	Buy	+16,195	New	+$1.1M	0.23%	144
2018 Q1	–	Sell	-18,647	Closed	-$766K	–	159
2017 Q4	$766K	Hold	18,647	–	–	0.11%	171
2017 Q3	$554K	Hold	18,647	–	–	0.08%	197
2017 Q2	$618K	Buy	18,647 +16,764	+890%	+$527K	0.26%	106
2017 Q1	$56K	Hold	1,883	–	–	0.07%	60
2016 Q4	$46.7K	Buy	+1,883	New	+$42.8K	0.84%	59

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Legato Capital Management's GMED Position: Q2 2026 in Review

Legato Capital Management increased its Globus Medical (GMED) stake by 53% in Q2 2026, buying an estimated $313K and bringing the position to 10,689 shares worth $845K. The position accounts for 0.07% of the portfolio, ranked #397.

Legato Capital Management first reported a position in GMED in Q4 2016 and has held it in 20 quarters since. The position peaked at $2.03M in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Legato Capital Management held 10,689 shares of Globus Medical worth $845K as of Q2 2026.
Legato Capital Management bought 3,680 Globus Medical shares in Q2 2026, an estimated $313K.
Globus Medical made up 0.07% of Legato Capital Management's portfolio in Q2 2026, its #397 holding.
Legato Capital Management first reported a position in Globus Medical in Q4 2016 and has held it in 20 quarters since.
Legato Capital Management's Globus Medical position peaked at $2.03M in Q4 2025.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.